FDA Approved: CORTROSYN — Supplemental Application (Amphastar Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Amphastar Pharmaceuticals' supplemental application for Cortrosyn (cosyntropin), a diagnostic agent used to assess adrenal function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Insufficiency

Drugs mentioned

• CORTROSYN (cosyntropin)

Snippet

SUPPL AP for CORTROSYN (COSYNTROPIN)